1980
DOI: 10.1001/archderm.1980.01640270033006
|View full text |Cite
|
Sign up to set email alerts
|

Sarcoidosis Responding to Allopurinol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0
1

Year Published

1980
1980
2003
2003

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(4 citation statements)
references
References 2 publications
0
3
0
1
Order By: Relevance
“…The role of mycophenolate mofetil remains to be established. Surgery may be of value in selected patients 2,15 , 23–27 . Well‐designed clinical trials are needed.…”
Section: Treatment Optionsmentioning
confidence: 99%
“…The role of mycophenolate mofetil remains to be established. Surgery may be of value in selected patients 2,15 , 23–27 . Well‐designed clinical trials are needed.…”
Section: Treatment Optionsmentioning
confidence: 99%
“…Other treatment modalities have been described, including methotrexate,15 azathioprine, peripheral vasodilators,4 and, recently, allopurinol. 16 Although daily corticosteroid therapy given for systemic effect alone has also been reported as being beneficial,5 we chose this regimen empirically and were pleased with its results. We included the antimalarial hydroxychloroquine because of its anti-inflammatory and immunosuppressive properties, hoping that it would be steroid sparing and might suppress lymphocyte transformation.17 The latter could be a critical treatment mechanism, since sarcoidosis may be a disease characterized by activated T lympho¬…”
Section: Report Of a Casementioning
confidence: 99%
“…Localized or systemic lesigns may undergo spontaneous remission in the early stages of the disease and treatment is sometimes reserved for advanced cases. Systemic lesions have responded favorably to systemic corticosteroids or allopurinol although the mortality rate for advanced disease remains approximately 5% (81,96).…”
Section: Sarcoidosismentioning
confidence: 99%